These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 2428394)
1. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells. Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394 [TBL] [Abstract][Full Text] [Related]
2. Antigenic characteristics of circulating CFU-GM in chronic granulocytic leukaemia resemble those of CFU-GM in normal marrow and differ from those in normal blood. Robak T; Nolasco I; Hibbin J; Goldman JM Leuk Res; 1985; 9(8):1023-9. PubMed ID: 2413317 [TBL] [Abstract][Full Text] [Related]
3. Antigenic phenotype of chronic granulocytic leukaemia progenitor cells in chronic phase and in blastic transformation characterized by means of monoclonal antibodies. Robak T Arch Immunol Ther Exp (Warsz); 1988; 36(4):471-85. PubMed ID: 3074744 [TBL] [Abstract][Full Text] [Related]
4. Expression of myeloid differentiation antigens on normal and chronic granulocytic leukemia erythroid progenitor cells identified by monoclonal antibodies. Robak T Arch Immunol Ther Exp (Warsz); 1987; 35(4):519-29. PubMed ID: 3481543 [TBL] [Abstract][Full Text] [Related]
5. Application of monoclonal antibodies in the antigenic characteristics of normal myeloid progenitor cells and clonogenic blasts in acute myeloid leukaemia. Robak T Arch Immunol Ther Exp (Warsz); 1988; 36(1):71-84. PubMed ID: 3233065 [TBL] [Abstract][Full Text] [Related]
6. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies. Hast R; Dowding C; Robak T; Goldman JM Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449 [TBL] [Abstract][Full Text] [Related]
7. HLA-DR monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukaemia myeloid progenitor cells. Goldman JM; Hibbin J; Kearney L; Orchard K; Th'ng KH Br J Haematol; 1982 Nov; 52(3):411-20. PubMed ID: 6957244 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia. Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231 [TBL] [Abstract][Full Text] [Related]
9. Specific binding of anti-N-acetyllactosamine monoclonal antibody 1B2 to acute myeloid leukaemia cells. Campos L; Portoukalian J; Bonnier S; Shi ZH; Calmard-Oriol P; Treille D; Guyotat D Eur J Cancer; 1992; 28(1):37-41. PubMed ID: 1567687 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies raised against K562 cells reacted with human haematopoietic pluripotent stem cells. Kubota Y; Tanaka T; Irino S Leuk Res; 1991; 15(4):195-204. PubMed ID: 2030600 [TBL] [Abstract][Full Text] [Related]
11. GM 58/8: a monoclonal antibody that identifies a new lineage-specific determinant expressed by myeloid progenitors (CFU-GM) and their progeny. Das Gupta A; Brice M; Yokochi T; Papayannopoulou T; Stamatoyannopoulos G Br J Haematol; 1984 Sep; 58(1):147-58. PubMed ID: 6205677 [TBL] [Abstract][Full Text] [Related]
12. Antigenic expression and proliferative status of multilineage myeloid progenitor cells (CFU-GEMM) in normal individuals and patients with chronic granulocytic leukaemia. Hibbin JA; McCarthy DM; Goldman JM Scand J Haematol; 1983 Nov; 31(5):454-60. PubMed ID: 6580719 [TBL] [Abstract][Full Text] [Related]
13. Antigenic characteristics of circulating granulocyte-macrophage progenitors (CFU-GM) in idiopathic myelofibrosis and polycythaemia vera defined by monoclonal antibodies. Robak T Arch Immunol Ther Exp (Warsz); 1989; 37(1-2):17-28. PubMed ID: 2619501 [TBL] [Abstract][Full Text] [Related]
14. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433 [TBL] [Abstract][Full Text] [Related]
16. Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitors. Larocca LM; Teofili L; Leone G; Sica S; Pierelli L; Menichella G; Scambia G; Benedetti Panici P; Ricci R; Piantelli M Br J Haematol; 1991 Dec; 79(4):562-6. PubMed ID: 1772777 [TBL] [Abstract][Full Text] [Related]
17. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture. Ball ED; Keefe KA; McDermott JM Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116 [TBL] [Abstract][Full Text] [Related]
18. SFL 23.6: a monoclonal antibody reactive with CFU-E, erythroblasts, and erythrocytes. Gupta AD; Samoszuk MK; Papayannopoulou T; Stamatoyannopoulos G Blood; 1985 Sep; 66(3):522-6. PubMed ID: 4027378 [TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation. Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448 [TBL] [Abstract][Full Text] [Related]
20. Immunophenotype of clonogenic cells in myeloid leukaemia. Kabral A; Bradstock KF; Grimsley P; Favaloro EJ Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]